Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 17, 2017
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancersRamona C Dolscheid-Pommerich, Mignon Keyver-Paik, Thomas Hecking, et al.Hormone Molecular Biology and Clinical Investigation|November 12, 2017
Preoperative breast MRI-examination for all patients with histologically proven breast cancer? A concept for a prospective multicenter trialChristina Kaiser, Christina Kehrer, Mignon-Denise Keyver-Paik, et al.Archives of Gynecology and Obstetrics|January 6, 2016
Individual management of cervical cancer in pregnancyThomas Hecking, Alina Abramian, Christian Domröse, et al.Anticancer Research|July 29, 2026
Tumoral PD-L1 Expression as a Prognostic Marker in Invasive Cervical CancerCarolin Schröder, Maryam Qureischi, Thomas Hecking, et al.Anticancer Research|April 13, 2016
Impact of Chemotherapy on Retroperitoneal Lymph Nodes in Ovarian CancerMignon-Denise Keyver-Paik, Janne Myriam Arden, Christine Lüders, et al.Breast Cancer Research and Treatment|February 19, 2018
Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapyYuri Tolkach, Heidrun Gevensleben, Ralph Bundschuh, et al.Anticancer Research|February 27, 2022
Programmed Cell Death Ligand-1 (PDL-1) Correlates With Tumor Infiltration by Immune Cells and Represents a Promising Target for Immunotherapy in Endometrial CancerThomas Hecking, Thore Thiesler, Janina Halbe, et al.Oncotarget|December 2, 2017
Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiologyThomas Hecking, Thore Thiesler, Cynthia Schiller, et al.Pageof 1